634 related articles for article (PubMed ID: 16479980)
21. Papillary renal cell carcinoma: a clinicopathological study of 35 cases.
Yamanaka K; Miyake H; Hara I; Inoue TA; Hanioka K; Fujisawa M
Int J Urol; 2006 Aug; 13(8):1049-52. PubMed ID: 16903928
[TBL] [Abstract][Full Text] [Related]
22. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
23. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
24. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract][Full Text] [Related]
25. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
26. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
Carini M; Minervini A; Lapini A; Masieri L; Serni S
J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
[TBL] [Abstract][Full Text] [Related]
27. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
28. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
29. Chromophobe renal cell carcinoma with osteosarcoma differentiation: case report and literature review.
Li YF; Cha TL; Jin JS; Yu CP
Urol Int; 2010; 85(4):470-4. PubMed ID: 20820103
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
[TBL] [Abstract][Full Text] [Related]
31. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature].
Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G
Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951
[TBL] [Abstract][Full Text] [Related]
32. [Chromophobe cell renal carcinoma: report of two cases].
Ito T; Nagae H; Maruyama S; Hadano S; Mugiya S; Suzuki K; Ozono S
Hinyokika Kiyo; 2003 Dec; 49(12):765-70. PubMed ID: 14978963
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and surgical management of renal cell carcinoma with inferior vena cava tumor thrombus--a report of 6 cases with literature review].
Li XD; Cheng S; Rui XF; Li GH; Chen YB; Yu DM
Ai Zheng; 2005 Nov; 24(11):1394-7. PubMed ID: 16552970
[TBL] [Abstract][Full Text] [Related]
34. pT1 substaging in renal cell carcinoma: validation of the 2002 TNM staging modification of malignant renal epithelial tumors.
Salama ME; Guru K; Stricker H; Peterson E; Peabody J; Menon M; Amin MB; De Peralta-Venturina M
J Urol; 2005 May; 173(5):1492-5. PubMed ID: 15821466
[TBL] [Abstract][Full Text] [Related]
35. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
[TBL] [Abstract][Full Text] [Related]
36. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
37. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
38. [Renal cell carcinoma metastatic to the base of tongue: a case report].
Kyan A; Kato SN
Hinyokika Kiyo; 2004 Nov; 50(11):791-3. PubMed ID: 15628540
[TBL] [Abstract][Full Text] [Related]
39. Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
Assouad J; Banu E; Brian E; Pham DN; Dujon A; Foucault C; Riquet M
Eur J Cardiothorac Surg; 2008 May; 33(5):794-8. PubMed ID: 18304831
[TBL] [Abstract][Full Text] [Related]
40. Performance status and cytoreductive nephrectomy: redefining management in patients with poor performance.
Shuch B; La Rochelle JC; Wu J; Klatte T; Riggs SB; Kabbinavar F; Belldegrun AS; Pantuck AJ
Cancer; 2008 Sep; 113(6):1324-31. PubMed ID: 18661529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
